MENU
DMRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Damora Therapeutics (DMRA) Earnings Date & Reports

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders... Show more

A.I. Advisor
published Earnings

DMRA is expected to report earnings to rise 33.33% to -51 cents per share on November 05

Damora Therapeutics DMRA Stock Earnings Reports
Q3'26
Est.
$-0.52
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.30
Q4'25
Missed
by $135.47
The last earnings report on August 10 showed earnings per share of -38 cents, beating the estimate of -43 cents. With 162.51K shares outstanding, the current market capitalization sits at 1.31B.